대한의료관련감염관리학회 Korean Society for Healthcare-associated infection Control and Prevention.

pISSN 0705-3797. eISSN 2586-1298.

Table. 2.

Table. 2.

Assessment of association of baseline characteristics with positive IGRA (n=45) among hemodialysis patients by using univariate and multivariate analysis

Risk factors IGRA positive
Results Uni-variate analysis Multi-variate analysis
n (%) OR (95% CI) P-value OR* (95% CI) P-value
Age, years <40 1/4 25.0 1.00 (reference) 1.00 (reference)
40-49 4/9 44.4 2.40 0.17-32.87 0.512 10.38 0.44-240.40 0.144
50-59 18/23 78.3 10.80 0.91-127.75 0.059 96.92 4.34-2163.52 0.004
60-69 12/26 46.2 2.57 0.23-28.08 0.439 5.49 0.31-95.74 0.242
>70 10/20 50.0 3.00 0.26-33.97 0.375 6.08 0.31-117.43 0.232
Gender Female 24/44 54.5 1.00 (reference) 1.00 (reference)
Male 21/38 55.3 1.02 0.43-2.46 0.948 0.55 0.09-3.35 0.523
BMI, kg/m2 18.5-24.9 27/49 55.1 1.00 (reference) 1.00 (reference)
<18.5 11/15 73.3 2.24 0.62-8.02 0.215 1.77 0.31-10.14 0.520
≥25 7/18 38.9 0.51 0.17-1.56 0.243 0.36 0.07-1.69 0.197
Smoking history No 26/53 49.1 1.00 (reference) 1.00 (reference)
Ex 17/23 73.9 0.51 0.08-3.08 0.471 0.42 0.02-7.48 0.558
Current 2/6 33.3 2.94 1.01-8.62 0.049 13.41 1.79-100.32 0.011
Contact history of TB No 34/68 50.0 1.00 (reference) 1.00 (reference)
Yes 11/14 78.6 3.66 0.93-14.31 0.062 12.64 1.88-84.89 0.009
DM No 23/41 56.1 1.00 (reference) 1.00 (reference)
Yes 22/41 53.7 0.90 0.38-2.16 0.824 4.30 0.97-18.93 0.054
HD-D, months <60 15/36 41.7 1.00 (reference) 1.00 (reference)
≥60 30/46 65.2 2.62 1.06-6.44 0.035 8.64 1.88-39.75 0.006
Hemoglobin, (g/dl) ≥10 39/73 53.4 1.00 (reference) 1.00 (reference)
<10 6/9 66.7 1.74 0.40-7.50 0.456 0.99 0.12-8.26 1.000
S-albumin, (mg/dl) ≥3.5 41/74 55.4 1.00 (reference) 1.00 (reference)
<3.5 4/8 50.0 0.80 0.18-3.46 0.771 1.04 0.11-9.29 0.971

*From a multivariate logistic regression model with age, gender, BMI, smoking history, contact history of TB, DM, HD-D, hemoglobin, and S-albumin.

Abbreviations: IGRA, interferon-gamma release assay; OR, odd ratio; CI, confidence interval; BMI, body mass index; Contact history of TB, contact history with active tuberculosis case; DM, diabetes mellitus; HD-D, hemodialysis duration; S, serum.

Korean J healthc assoc Infect Control Prev 2021;26:96~100 https://doi.org/10.14192/kjicp.2021.26.2.96
© Korean J healthc assoc Infect Control Prev